Un meta-anlisis reciente (2024) de ensayos clnicos sugiere que el riesgo no es significativamente mayor que el placebo en condiciones controladas, pero la precaucin clnica se mantiene
Research Evidence Comparison# Pemvidutide Research# Key trials include MOMENTUM (Phase 2, obesity, 15.6% weight loss at 48 weeks with 2.4 mg), IMPACT (Phase 2b, MASH, up to 59.1% MASH resolution at 24 weeks, 48-week data showing key measures of success), and RECLAIM (Phase 2, alcohol use disorder, enrolling)
Comparative effectiveness research with established therapies would help determine the relative benefits and risks of these peptides compared to current standard treatments and would inform evidence-based treatment decisions
Reconstituted Peptide: Once mixed with Bacteriostatic Water , the peptide must be kept in a refrigerator at 2-8C and used within 1430 days
Finally, if youre on other medications, interactions may play a role in why youre developing headaches